Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 22/01/21 → 31/12/22 |
Funding
- UK central government bodies/local authorities, health and hospital authorities: £21,120.00
Predictive value of Philips OncoSignal pathway activity scores on biopsies from patients with ER+ stained breast cancer to their response to Letrozole neoadjuvant therapy - NHS Lothian Performance Evaluation Study
- Turnbull, Arran (Principal Investigator)
- Sims, Andrew (Co-investigator)